To mark Tuesday’s World Cervical Cancer Elimination Day, global health leaders emphasized the strides achieved and the growing likelihood that cervical cancer will become a disease of the past.

For the first time in public‑health history, the prospect of eliminating a cancer is within sight. The necessary tools—HPV vaccination, screening and timely treatment—are already available, making cervical cancer the first malignancy that could be eradicated.

Each year more than 600,000 women are diagnosed with cervical cancer and roughly 280,000 die. Behind each statistic is a woman whose life, family and future matter. When a mother succumbs, her children become “maternal orphans,” left to grow up without her love, protection and support—a loss that ripples through families, communities and generations.

Women in the world’s poorest places are the most affected.

The disease burden is starkly unequal. Cervical cancer disproportionately affects women and families in the world’s poorest communities, with 19 of the 20 highest‑burden countries located in the WHO African Region. Beyond the physical toll of advanced disease, many women confront stigma, silence and formidable barriers to life‑saving care.

That urgency spurred the WHO to issue a bold call for action in 2018. Nations have responded. In 2020, even amid the COVID‑19 pandemic, WHO member states adopted a “Global Strategy to Accelerate the Elimination of Cervical Cancer.” The strategy sets ambitious yet achievable targets: vaccinating 90 % of girls against HPV, screening 70 % of women and ensuring 90 % access to treatment for those with precancerous lesions or cancer.

Science, solidarity and commitment are delivering results.

At a time when the world often seems overwhelmed by intractable problems, cervical cancer elimination offers a different story: one of science, solidarity and sustained commitment delivering results.

Progress is accelerating. Australia and Sweden are approaching the historic milestone of eliminating cervical cancer as a public‑health problem, while Rwanda demonstrates that similar success is possible in Africa, with several districts already meeting key WHO elimination targets.

Six years after the strategy’s launch, the landscape has changed dramatically. Once‑critical vaccine‑supply constraints have largely been resolved, and the market now offers a broader range of HPV vaccines. Today, 166 countries have integrated HPV vaccination into their national programmes—including Burundi, Papua New Guinea and Ukraine in the past year alone. India recently rolled out one of the world’s largest HPV campaigns, reaching more than 11 million girls.

Meanwhile, scientific advances have enabled a simplified single‑dose schedule for most girls, making vaccination easier and more affordable at scale. Ninety‑six countries now report using a one‑dose regimen, and global HPV vaccination coverage has risen to 33 %.

Screening and treatment are advancing alongside prevention provided by vaccination.

Screening and treatment have also progressed. More countries are adopting HPV testing, which outperforms the traditional Pap test or visual inspection with vinegar in low‑resource settings. Modern HPV tests even let women collect their own samples, enhancing privacy and convenience, while portable thermal ablation devices enable nurses to treat precancerous lesions within minutes—even in remote communities. Emerging tools such as AI‑assisted screening promise to sharpen early detection and further accelerate elimination efforts.

Behind these advances stands something just as powerful: a growing global movement.

The heroes of this global movement are survivors, advocates, health workers and community leaders who are turning the promise of elimination into reality.

In Kenya, nurse Martha Wanjiru operates a mobile clinic across the highlands of Kiambu County, bringing screening services directly to women in urban settlements and rural communities while educating them about their health. Kenya is now advancing a national elimination action plan, transitioning to single‑dose vaccination and expanding integrated screening services.

In Sierra Leone, health‑worker Sallay Carew takes her bullhorn into Freetown’s bustling markets, loudly breaking down stigma as she urges women to get screened. Today, screening services are available across all 16 districts. Through a training partnership with Zambian colleagues, Sierra Leone’s gynecologists now perform life‑saving cervical‑cancer surgery, provided free of charge. Women who once had to travel abroad for care can now receive it at home.

Bravest of all are the survivors leading change. In Zambia, Karen Nakawala used her radio show to broadcast her battle with cervical cancer nationwide. She organized HPV‑vaccination drives and screening campaigns to push toward WHO targets, and her “Teal Sisters” network now numbers more than 100,000 members. The sisters accompany one another through treatment and survivorship. In Malaysia, Selina Yeop is building a grassroots network of survivors. With teal‑colored fashion shows, peer‑support groups and heads held high, they are reshaping how the country talks about cervical cancer. Across borders and continents, survivors are connecting, organising and leading.

Their efforts are matched by political commitment. Last year, governments meeting at the World Health Assembly reaffirmed their determination to eliminate cervical cancer and designated 17 November as World Cervical Cancer Elimination Day.

These achievements deserve celebration. Yet the momentum is not a licence to slow down. Too many women are still being left behind.

Governments must sustain investment in vaccination, screening and treatment until every woman and girl can access the services she needs, regardless of where she lives. Women living with HIV deserve special attention. They face a six‑fold higher risk of developing cervical cancer. While the HIV/AIDS movement has delivered extraordinary results over the past four decades, we are falling short on this front. A comprehensive package of care must include the cervical‑cancer services that women need, too. As countries adapt to a changing global health‑financing landscape, investing in cervical‑cancer prevention is far more sustainable than confronting the disease’s consequences.

Industry also has a critical role. Vaccines, diagnostic tests and treatment technologies must be available at prices that enable all countries—especially low‑ and middle‑income nations—to continue scaling up access. Elimination will be possible only if innovation is matched by affordability.

Be part of making history on this World Cervical Cancer Elimination Day

Our message is simple: history is waiting to be made, so choose to be part of it. The tools exist. The strategy is clear. The momentum is real.

Now we need every government, every health worker, every community leader, every parent and every advocate to help carry this movement forward. Vaccinate your children. Get screened. Support someone you love to access care. Advocate for services in your community. Put on a teal ribbon and start a conversation: tell others that you, too, are standing up for women’s health, for the end of cancer, and for the unifying power of public health.

If we sustain the commitment that countries and communities have already shown, cervical cancer can become the first cancer humanity eliminates as a public‑health problem. Millions of women and girls will live longer and healthier lives. And future generations will know that when the world had the chance to end this suffering, we chose to finish the job.

Dr Tedros Adhanom Ghebreyesus is WHO Director‑Genera. Dr Princess Nono Simelela is Advisor to the Minister of Healt of South Africa. Prof Groesbeck Parham is Consultant Gynecologic Oncologis at the University of Zambia. Richard Freeman is Executive Officer of WHO. Dr Prebo Barango is WHO Cross-Cutting Specialist for NCDs and Special Initiatives. Claire Kimilu is Consultant, WHO Cervical Cancer Elimination Initiative.

Source link

Exit mobile version